Differential Expression of Cytochrome P450 Enzymes from the CYP2C Subfamily in the Human Brain-Reference-Cited by-同舟云学术

Differential Expression of Cytochrome P450 Enzymes from the CYP2C Subfamily in the Human Brain

Published:2014-12-11 Issue:3 Volume:43 Page:353-357
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Booth Depaz Iris M.,Toselli Francesca,Wilce Peter A.,Gillam Elizabeth M. J.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference20 articles.

1. Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow;Alkayed;Am J Physiol,1996

2. Differential Expression of Human Cytochrome P450 Enzymes from the CYP3A Subfamily in the Brains of Alcoholic Subjects and Drug-Free Controls

3. Phenytoin metabolism by human cytochrome P450: involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation;Cuttle;Drug Metab Dispos,2000

4. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier

5. Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure;Drug Metabolism Reviews;2023-12-21

2. Dihydroxy-Metabolites of Dihomo-γ-linolenic Acid Drive Ferroptosis-Mediated Neurodegeneration;ACS Central Science;2023-03-16

3. Biotransformation of Efavirenz and Proteomic Analysis of Cytochrome P450s and UDP-Glucuronosyltransferases in Mouse, Macaque, and Human Brain-Derived In Vitro Systems;Drug Metabolism and Disposition;2023-01-09

4. Dihydroxy-Metabolites of Dihomo-gamma-linolenic Acid Drive Ferroptosis-Mediated Neurodegeneration;2023-01-05

5. CYP450 2D6 and 2C19 genotypes in ADHD: not related with treatment resistance but with over-representation of 2C19 ultra-metabolizers;Drug Metabolism and Personalized Therapy;2022-02-24